Julie Beitz was named principal drug regulatory expert at Hyman, Phelps & McNamara, P.C., a law firm focused on FDA.
The Supreme Court last week upended one of the underpinnings of administrative law by weakening the authority of federal health agencies to rely on technical expertise as they regulate medical products, issue coverage decisions, and respond to public health crises.
